Clinical Trial

Impact of Remote Care in Patients Diagnosed With Thromboembolic Disease of Low Risk

Study acronym: TEVEDOM
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn about the feasibility and impact of remote care in patients diagnosed with thromboembolic disease of low risk. The main questions it aims to answer are: * the evaluation of feasibility of organisation between different healthcare professionals (hospital physicians, primary care physician) at 6 months and 1 year * the evaluation of complication rate, hospitalisation related to thromboembolic disease rate, compliance to treatment rate at 6 months and 1 year Participants will receive indication of treatment according to national recommendations. Additionnally, they will receive for the length of study a 4G tablet in order to fill questionnaires, learn information about their drugs (patient education), have a remote consultation and evaluate treatment compliance.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-01-12.
Status change: Not Yet Recruiting → Recruiting 2025-09-09
Trial Details
NCT Number NCT05684770
Lead Sponsor Centre Hospitalier Eure-Seine
Conditions Thromboembolic Disease
Enrollment 50 participants
Start Date 2025-09
Primary Completion 2027-03 (estimated)
Study Completion 2028-03 (estimated)
Updated on ClinicalTrials.gov 2025-09-15